{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T04:04:33Z","timestamp":1782360273057,"version":"3.54.5"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100017147","name":"International Progressive MS Alliance","doi-asserted-by":"crossref","award":["PA-1603-08175"],"award-info":[{"award-number":["PA-1603-08175"]}],"id":[{"id":"10.13039\/100017147","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100012498","name":"Alzheimer Society Research Program","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012498","id-type":"DOI","asserted-by":"crossref"}]},{"name":"ASRP"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,6,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diffusely abnormal white matter, characterised by biochemical changes of myelin in the absence of frank demyelination, has been associated with clinical progression in secondary progressive multiple sclerosis. However, little is known about changes of diffusely abnormal white matter over time and their relation to focal white matter lesions.<\/jats:p>\n                  <jats:p>The objectives of this work were: (i) to characterize the longitudinal evolution of focal white matter lesions, diffusely abnormal white matter and diffusely abnormal white matter that transforms into focal white matter lesions; and (ii) to determine whether gadolinium enhancement, known to be associated with the development of new focal white matter lesions, is also related to diffusely abnormal white matter voxels that transform into focal white matter lesions.<\/jats:p>\n                  <jats:p>Our data included 4220 MRI scans of 689 secondary progressive multiple sclerosis participants, followed for 156 weeks, and 2677 scans of 686 relapsing-remitting multiple sclerosis participants, followed for 96 weeks. Focal white matter lesions and diffusely abnormal white matter were segmented using a previously validated, automatic thresholding technique based on normalized T2 intensity values. Using longitudinally registered images, diffusely abnormal white matter voxels at each visit that transformed into focal white matter lesions on the last MRI scan as well as their overlap with gadolinium-enhancing lesion masks were identified.<\/jats:p>\n                  <jats:p>Our results showed that the average yearly rate of conversion of diffusely abnormal white matter to focal white matter lesions was 1.27\u2005cm3 for secondary progressive multiple sclerosis and 0.80\u2005cm3 for relapsing-remitting multiple sclerosis. Focal white matter lesions in secondary progressive multiple sclerosis participants significantly increased (t\u2009=\u20093.9; P\u2009=\u20090.0001) while diffusely abnormal white matter significantly decreased (t\u2009=\u2009\u22124.3 P\u2009&amp;lt;\u20090.0001) and the ratio of focal white matter lesions to diffusely abnormal white matter increased (t\u2009=\u200912.7; P\u2009&amp;lt;\u20090.00001). Relapsing-remitting multiple sclerosis participants also showed an increase in the focal white matter lesions to diffusely abnormal white matter ratio (t\u2009=\u20096.9; P\u2009&amp;lt;\u20090.00001) but without a significant change of the individual volumes. Gadolinium enhancement was associated with 7.3% and 18.7% of focal new T2 lesion formation in the infrequent scans of the relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis cohorts, respectively. In comparison, only 0.1% and 0.0% of diffusely abnormal white matter to focal white matter lesions voxels overlapped with gadolinium enhancement.<\/jats:p>\n                  <jats:p>We conclude that diffusely abnormal white matter transforms into focal white matter lesions over time in both relapsing-remitting multiple sclerosis and secondary progressive multiple sclerosis. Diffusely abnormal white matter appears to represent a form of pre-lesional pathology that contributes to T2 lesion volume increase over time, independent of new focal inflammation and gadolinium enhancement.<\/jats:p>","DOI":"10.1093\/brain\/awab448","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T23:14:58Z","timestamp":1639696498000},"page":"2008-2017","source":"Crossref","is-referenced-by-count":10,"title":["Diffusely abnormal white matter converts to T2 lesion volume in the absence of MRI-detectable acute inflammation"],"prefix":"10.1093","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-2672","authenticated-orcid":false,"given":"Mahsa","family":"Dadar","sequence":"first","affiliation":[{"name":"Radiology Department, Faculty of Medicine, Laval University , Quebec, Quebec , Canada"},{"name":"Department of Biomedical Engineering, McGill University , Montreal, Quebec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan","family":"Mahmoud","sequence":"additional","affiliation":[{"name":"Department of Anatomy, University of Quebec in Trois-Rivieres , Trois-Rivieres, Quebec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridar","family":"Narayanan","sequence":"additional","affiliation":[{"name":"McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University , Montreal, Quebec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D Louis","family":"Collins","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, McGill University , Montreal, Quebec , Canada"},{"name":"McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University , Montreal, Quebec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas L","family":"Arnold","sequence":"additional","affiliation":[{"name":"McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University , Montreal, Quebec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9696-5522","authenticated-orcid":false,"given":"Josefina","family":"Maranzano","sequence":"additional","affiliation":[{"name":"Department of Anatomy, University of Quebec in Trois-Rivieres , Trois-Rivieres, Quebec , Canada"},{"name":"McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University , Montreal, Quebec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"2022070101371894900_awab448-B1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"2022070101371894900_awab448-B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000367614","article-title":"New multiple sclerosis phenotypic classification","volume":"72","author":"Lublin","year":"2014","journal-title":"Eur Neurol"},{"key":"2022070101371894900_awab448-B3","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1212\/01.WNL.0000046587.83503.1E","article-title":"MRI contrast uptake in new lesions in relapsing\u2013remitting MS followed at weekly intervals","volume":"60","author":"Cotton","year":"2003","journal-title":"Neurology"},{"key":"2022070101371894900_awab448-B4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrneurol.2016.59","article-title":"Advanced MRI and staging of multiple sclerosis lesions","volume":"12","author":"Absinta","year":"2016","journal-title":"Nat Rev Neurol"},{"key":"2022070101371894900_awab448-B5","doi-asserted-by":"crossref","first-page":"1756286419859722","DOI":"10.1177\/1756286419859722","article-title":"Advances in brain imaging in multiple sclerosis","volume":"12","author":"Cortese","year":"2019","journal-title":"Ther Adv Neurol Disord"},{"key":"2022070101371894900_awab448-B6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/1352458510384008","article-title":"Pathological basis of diffusely abnormal white matter: insights from magnetic resonance imaging and histology","volume":"17","author":"Laule","year":"2011","journal-title":"Mult Scler"},{"key":"2022070101371894900_awab448-B7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/NEN.0b013e31827bced3","article-title":"Diffusely abnormal white matter in multiple sclerosis: Further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration","volume":"72","author":"Laule","year":"2013","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022070101371894900_awab448-B8","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain"},{"key":"2022070101371894900_awab448-B9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneurol.2009.57","article-title":"Diffusely abnormal white matter in chronic multiple sclerosis: Imaging and histopathologic analysis","volume":"66","author":"Seewann","year":"2009","journal-title":"Arch Neurol"},{"key":"2022070101371894900_awab448-B10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1177\/1352458520912172","article-title":"Conversion of diffusely abnormal white matter to focal lesions is linked to progression in secondary progressive multiple sclerosis","volume":"27","author":"Dadar","year":"2021","journal-title":"Mult Scler"},{"key":"2022070101371894900_awab448-B11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/jon.12574","article-title":"Diffusely abnormal white matter, T2 burden of disease, and brain volume in relapsing\u2013remitting multiple sclerosis","volume":"29","author":"Vertinsky","year":"2019","journal-title":"J Neuroimaging"},{"key":"2022070101371894900_awab448-B12","doi-asserted-by":"crossref","first-page":"116690","DOI":"10.1016\/j.neuroimage.2020.116690","article-title":"Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis","volume":"213","author":"Maranzano","year":"2020","journal-title":"Neuroimage"},{"key":"2022070101371894900_awab448-B13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41582-018-0082-z","article-title":"Treatment of multiple sclerosis\u2014Success from bench to bedside","volume":"15","author":"Tintore","year":"2019","journal-title":"Nat. Rev. Neurol"},{"key":"2022070101371894900_awab448-B14","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"key":"2022070101371894900_awab448-B15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1109\/42.668698","article-title":"A nonparametric method for automatic correction of intensity nonuniformity in MRI data","volume":"17","author":"Sled","year":"1998","journal-title":"IEEE Trans Med Imaging"},{"key":"2022070101371894900_awab448-B16","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1016\/j.neuroimage.2011.09.012","article-title":"BEaST: Brain extraction based on nonlocal segmentation technique","volume":"59","author":"Eskildsen","year":"2012","journal-title":"Neuroimage"},{"key":"2022070101371894900_awab448-B17","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/mrm.28547","article-title":"BISON: Brain tissue segmentation pipeline using T1-weighted magnetic resonance images and a random forests classifier","volume":"85","author":"Dadar","year":"2019","journal-title":"Magn Reson Med"},{"key":"2022070101371894900_awab448-B18","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroimage.2018.03.025","article-title":"A comparison of publicly available linear MRI stereotaxic registration techniques","volume":"174","author":"Dadar","year":"2018","journal-title":"Neuroimage"},{"key":"2022070101371894900_awab448-B19","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1006\/nimg.1997.0299","article-title":"Incorporating prior knowledge into image registration","volume":"6","author":"Ashburner","year":"1997","journal-title":"Neuroimage"},{"key":"2022070101371894900_awab448-B20","volume-title":"A Bayesian framework for 4-D segmentation of Multiple Sclerosis lesions in serial MRI in the brain","author":"Elliott","year":"2016"},{"key":"2022070101371894900_awab448-B21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1474-4422(18)30069-3","article-title":"Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): A phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension","volume":"17","author":"Kapoor","year":"2018","journal-title":"Lancet Neurol"},{"key":"2022070101371894900_awab448-B22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa1601277","article-title":"Ocrelizumab versus interferon beta-1a in relapsing multiple sclerosis","volume":"376","author":"Hauser","year":"2017","journal-title":"N Engl J Med"},{"key":"2022070101371894900_awab448-B23","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","article-title":"Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)","volume":"33","author":"Kurtzke","year":"1983","journal-title":"Neurology"},{"key":"2022070101371894900_awab448-B24","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1177\/1352458518814117","article-title":"Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions","volume":"25","author":"Elliott","year":"2018","journal-title":"Mult Scler"},{"key":"2022070101371894900_awab448-B25","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/jamaneurol.2020.1568","article-title":"Contribution of relapse-independent progression vs relapse-associated worsening to overall confirmed disability accumulation in typical relapsing multiple sclerosis in a pooled analysis of 2 randomized clinical trials","volume":"77","author":"Kappos","year":"2020","journal-title":"JAMA Neurol"},{"key":"2022070101371894900_awab448-B26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0165-5728(82)90037-6","article-title":"Immunocytochemical study of myelin-associated glycoprotein (MAG) and basic protein (BP) in acute experimental allergic encephalomyelitis (EAE)","volume":"3","author":"Itoyama","year":"1982","journal-title":"J Neuroimmunol"},{"key":"2022070101371894900_awab448-B27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jnen\/62.1.25","article-title":"Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases","volume":"62","author":"Aboul-Enein","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"2022070101371894900_awab448-B28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ana.410070212","article-title":"Immunocytochemical observations on the distribution of myelin-associated glycoprotein and myelin basic protein in multiple sclerosis lesions","volume":"7","author":"Itoyama","year":"1980","journal-title":"Ann Neurol"},{"key":"2022070101371894900_awab448-B29","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1474-4422(13)70103-0","article-title":"MRI lesions as a surrogate for relapses in multiple sclerosis: A meta-analysis of randomised trials","volume":"12","author":"Sormani","year":"2013","journal-title":"Lancet Neurol"},{"issue":"7","key":"2022070101371894900_awab448-B30","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/brain\/122.7.1261","article-title":"Spatial mapping of T2 and gadolinium-enhancing T1 lesion volumes in multiple sclerosis: Evidence for distinct mechanisms of lesion genesis?","volume":"122","author":"Lee","year":"1999","journal-title":"Brain"},{"key":"2022070101371894900_awab448-B31","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.amjmed.2020.05.049","article-title":"Treatment of multiple sclerosis: A review","volume":"133","author":"Hauser","year":"2020","journal-title":"Am J Med"},{"key":"2022070101371894900_awab448-B32","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1172\/JCI86198","article-title":"Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions","volume":"126","author":"Absinta","year":"2016","journal-title":"J Clin Invest"},{"key":"2022070101371894900_awab448-B33","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1002\/hbm.22410","article-title":"Surface-based analysis reveals regions of reduced cortical magnetization transfer ratio in patients with multiple sclerosis: A proposed method for imaging subpial demyelination","volume":"35","author":"Derakhshan","year":"2014","journal-title":"Hum Brain Mapp"},{"key":"2022070101371894900_awab448-B34","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/WNL.0000000000004227","article-title":"MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosis","volume":"89","author":"Maranzano","year":"2017","journal-title":"Neurology"},{"key":"2022070101371894900_awab448-B35","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/01.wnl.0000345970.73354.17","article-title":"Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study","volume":"72","author":"Cadavid","year":"2009","journal-title":"Neurology"},{"key":"2022070101371894900_awab448-B36","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/WNL.40.4.591","article-title":"Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis","volume":"40","author":"Bastianello","year":"1990","journal-title":"Neurology"},{"key":"2022070101371894900_awab448-B37","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1007\/s00415-020-09894-1","article-title":"The contribution of enhancing lesions in monitoring multiple sclerosis treatment: Is gadolinium always necessary?","volume":"267","author":"Tsantes","year":"2020","journal-title":"J Neurol"},{"key":"2022070101371894900_awab448-B38","first-page":"614","article-title":"Gadolinium-enhanced susceptibility-weighted imaging in multiple sclerosis: Optimizing the recognition of active plaques for different MR imaging sequences","volume":"40","author":"do Amaral","year":"2019","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022070101371894900_awab448-B39","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1093\/brain\/aww008","article-title":"White matter hyperintensities and imaging patterns of brain ageing in the general population","volume":"139","author":"Habes","year":"2016","journal-title":"Brain"},{"key":"2022070101371894900_awab448-B40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s13195-020-00669-4","article-title":"White matter hyperintensities across the adult lifespan: Relation to age, A\u03b2 load, and cognition","volume":"12","author":"Garnier-Crussard","year":"2020","journal-title":"Alzheimers Res Ther"},{"key":"2022070101371894900_awab448-B41","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neurobiolaging.2019.08.024","article-title":"The relationship between white matter hyperintensities and cognitive reference abilities across the life span","volume":"83","author":"Moura","year":"2019","journal-title":"Neurobiol Aging"},{"key":"2022070101371894900_awab448-B42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.neurobiolaging.2018.03.012","article-title":"Nonlinear pattern of the emergence of white matter hyperintensity in healthy Han Chinese: an adult lifespan study","volume":"67","author":"Huang","year":"2018","journal-title":"Neurobiol Aging"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awab448\/43683786\/awab448.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/6\/2008\/44360330\/awab448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/145\/6\/2008\/44360330\/awab448.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T21:41:42Z","timestamp":1656625302000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/145\/6\/2008\/6470368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,12,20]]},"published-print":{"date-parts":[[2022,6,30]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awab448","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.09.455717","asserted-by":"object"}]},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,6,1]]},"published":{"date-parts":[[2021,12,20]]}}}